Diabetes Obes Metab. 2021 Jun 3.
Aim: To evaluate the efficacy and safety of basal-bolus insulin therapy in managing glycaemia during fasting periods in hospitalized patients with type 2 diabetes.
Aims: To investigate efficacy, safety and usability of the GlucoTab system for glycaemic management using insulin glargine U300 in non-critically ill hospitalized patients with type 2 diabetes (T2D).
This article reports on results from the first clinical trial performed with the prototype of the GlucoTab® system, a mobile, tablet-based client-server system for computerized decision and workflow support.
GlucoTab® clinical evaluation of 99 patients across 4 different wards at the University Hospital of Graz: